ARCHIVES

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Grants Accelerated Approval To Ferriprox for Iron Overload

October 28, 2011

Congress Asked To Equalize Cuts, Add $20 million For Centers

April 25, 1980

Freshman Congressman Launches Drive for “Adequate” Cancer Research Funding

August 5, 1983

Stand Up To Cancer Awards 13 Grants

January 15, 2010

NCI Tells CCOPs To Slow Patient Accrual To Clinical Trials, Prepare For Budget Cuts.

May 12, 2006

Former Senator Cotton Named To NCA

April 11, 1975